Welcome to our dedicated page for Advanced Flower Capital SEC filings (Ticker: AFCG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Advanced Flower Capital Inc. (Nasdaq: AFCG) provide detailed insight into the company’s evolution from a commercial mortgage real estate investment trust to a business development company (BDC) and its ongoing lending activities. As a Maryland corporation based in West Palm Beach, Florida, Advanced Flower Capital files periodic and current reports that describe its loan portfolio, capital structure, governance arrangements and regulatory status.
Through this page, investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include information on GAAP net income or loss, the composition and performance of the loan portfolio, credit loss provisions, and the company’s non-GAAP measure, Distributable Earnings, as defined in its filings. These reports also discuss risk factors related to lending in the cannabis industry, concentration of loans, access to financing and the implications of operating under REIT and BDC regulatory frameworks.
Current reports on Form 8-K are particularly relevant for tracking material events at Advanced Flower Capital. Recent 8-K filings have covered the announcement of quarterly financial results, shareholder votes on proposals to facilitate the conversion from a REIT to a BDC, and the adoption of a 1940 Act-compliant investment advisory agreement with AFC Management, LLC. Such filings also document the application of reduced asset coverage requirements permitted for BDCs and the effective date of the company’s conversion.
Investors can also use this page to access proxy materials such as the definitive proxy statement on Schedule 14A, which explains the rationale for the conversion to a BDC, outlines changes to the company’s investment strategy and regulatory obligations, and summarizes risks and considerations associated with the new structure. In addition, filings related to dividends, credit facilities and other financing arrangements help readers understand how Advanced Flower Capital funds and manages its senior secured loans and other debt investments.
Stock Titan’s platform supplements these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as changes in leverage, updates to the investment mandate, and material developments affecting AFCG’s shareholders.
Amendment No. 2 to a Schedule 13D reports that Leonard M. Tannenbaum beneficially owns 6,241,981 shares of Advanced Flower Capital Inc., representing 27.6% of the 22,594,541 shares outstanding as of August 13, 2025. The filing states Mr. Tannenbaum acquired additional Common Stock in multiple open market purchases since his prior Schedule 13D/A on July 2, 2024, using personal funds; those transactions are said to be listed on Schedule A. His holdings include 4,148,243 shares held directly, 186,780 shares of restricted stock and 1,906,958 shares issuable upon exercise of options exercisable within 60 days. The filing disclaims beneficial ownership of 180,400 shares held by the Tannenbaum Family Foundation and 211,827 shares held by his spouse.
Neville Daniel, Chief Executive Officer and director of Advanced Flower Capital Inc. (AFCG), purchased 10,000 shares of the company's common stock on 08/25/2025 at a weighted average price of $4.04 per share. Following the transaction, Mr. Daniel beneficially owned 197,261 shares. The Form 4 was filed indicating the transaction code "P" and includes a note that the trades were executed in multiple fills at prices ranging from $4.00 to $4.05; the reported $4.04 is the weighted average. The filing was signed by an attorney-in-fact on 08/26/2025.
Insider purchases increased Robyn Tannenbaum's direct stake in Advanced Flower Capital Inc. (AFCG). The Form 4 shows Ms. Tannenbaum, President and CIO, bought 2,000 shares on 08/22/2025 at an average price of $4.10 and 4,000 shares on 08/25/2025 at an average price of $4.13, for a total of 6,000 newly acquired shares. After these purchases she directly owns 127,667 shares. The filing also reports indirect holdings: 4,335,023 shares held by her spouse and 180,400 shares held by the Tannenbaum Family Foundation, of which she disclaims beneficial ownership except for any pecuniary interest. The report is signed by an attorney-in-fact on 08/26/2025.
Leonard M. Tannenbaum, a director and reported 10% owner of Advanced Flower Capital Inc. (AFCG), filed a Form 4 disclosing multiple open-market purchases of common stock on August 22, 25 and 26, 2025. The filings report acquisitions of 216,117 shares at a weighted average price of $4.03 on August 22, 61,862 shares at $4.08 on August 25, and 97,168 shares at $4.17 on August 26, bringing his directly held shares to 4,335,023.
The report also shows 127,667 shares held by his spouse and 180,400 shares held by the Tannenbaum Family Foundation, for which he serves as President; he disclaims beneficial ownership of those holdings except to the extent of any pecuniary interest. The Form 4 is signed by an attorney-in-fact on August 26, 2025.
Advanced Flower Capital Inc. provides a fragmented excerpt of its proposed proxy materials showing capital-definition text, expense and hypothetical performance tables and pro forma leverage scenarios. The filing states $201.4 million in net assets and actual total assets of $402.1 million with $190.0 million of outstanding indebtedness as of December 31, 2024, and a weighted average effective interest rate on outstanding debt of 6.93%. The document models two pro forma leverage frameworks: a 200% asset coverage scenario with $201.3 million of debt and a 150% asset coverage scenario with $402.5 million of debt.
The tables show hypothetical pre-incentive net investment income rates and expense estimates under each coverage scenario and provide estimated annual interest payments and incentive fee assumptions tied to the Proposed Investment Advisory Agreement. The filing clarifies certain expense assumptions and states that maximum borrowings presented are for comparative informational purposes only.
Advanced Flower Capital Inc. (AFCG) furnished a press release on August 14, 2025 announcing its financial and operational results for the quarter ended June 30, 2025. The Form 8-K states the press release is included as Exhibit 99.1 and clarifies that the furnished information is not deemed "filed" under certain Exchange Act and Securities Act provisions.
The 8-K text does not include any numeric financial results or operational metrics; the press release itself (Exhibit 99.1) must be consulted for the company’s detailed figures and disclosures.
Advanced Flower Capital Inc. (AFCG) reported a continuing operations net loss of $(13,164,651) for the three months ended June 30, 2025, compared with net income of $15,206,224 in the prior-year quarter. Interest income declined to $8.06 million from $17.98 million and net interest income fell to $6.20 million. Total assets decreased to $290.59 million from $402.06 million and cash fell to $3.41 million from $103.61 million at year-end. The Company recorded a CECL reserve of $43.96 million (about 14.61% of loans) and holds a fair-value senior loan to Private Company A with an approximate $21.47 million unrealized loss. Revolver borrowings were $10.4 million and $90.0 million principal of 2027 senior notes remain outstanding. The Board approved an expansion of the investment strategy, subject to shareholder approval.